SEC Company Response from PDS Biotechnology Corp (PDSB) (CIK 0001472091) (PDSB) — Feb 10, 2020

PDS Biotechnology Corp (PDSB) (CIK 0001472091)
Date: Feb. 10, 2020 · CIK: 0001472091 · Accession: 0001140361-20-002732

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-235549

Date

February 10, 2020

Author

PDS BIOTECHNOLOGY CORPORATION

Form

CORRESP

Company

PDS Biotechnology Corp (PDSB) (CIK 0001472091)

Letter

February 10, 2020

VIA EDGAR

Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549

Attention:

Suzanne Hayes

Assistant Director

Re:

PDS Biotechnology Corporation

Registration Statement on Form S-1

File No. 333-235549

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-235549) (the “Registration Statement”), so that the Registration Statement may become effective at 5:00 p.m. (Washington, D.C. time) on February 11, 2020 or as soon as practicable thereafter. This acceleration request amends, restates and supersedes in its entirety the previously submitted acceleration request submitted on February 7, 2020.

Sincerely,
PDS BIOTECHNOLOGY CORPORATION

Show Raw Text

CORRESP
1
filename1.htm

    February 10, 2020

    VIA EDGAR

    Securities and Exchange Commission

    100 F. Street, N.E.

    Washington, D.C. 20549

            Attention:

            Suzanne Hayes

            Assistant Director

            Re:

            PDS Biotechnology Corporation

            Registration Statement on Form S-1

            File No. 333-235549

    Ladies and Gentlemen:

    Pursuant to Rule 461 under the Securities Act of 1933, as amended, PDS Biotechnology Corporation hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No.
      333-235549) (the “Registration Statement”), so that the Registration Statement may become effective at 5:00 p.m. (Washington, D.C. time) on February 11, 2020 or as soon as practicable thereafter. This acceleration request amends, restates and
      supersedes in its entirety the previously submitted acceleration request submitted on February 7, 2020.

    Sincerely,

    PDS BIOTECHNOLOGY CORPORATION

    By: /s/ Frank Bedu-Addo, Ph.D.

    Name: Frank Bedu-Addo, Ph.D.

    Title: President and Chief Executive Officer

SecProbe.io